Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Blue Haven RX vs Claya

Blue Haven RX
Graded #489

Lower grade

vs+12
Claya
Graded #264

Higher grade

The verdict

Claya takes it — 62.8/100 to 50.8/100.

Claya grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBlue Haven RX +3
45
42
Dose & formulationClaya +35
40
75
Clinical oversightClaya +13
69
82
Labs & monitoringClaya +2
51
53
FulfillmentBlue Haven RX +4
71
67
Contract termsClaya +41
20
61
Blue Haven RX · left barClaya · right bar

The numbers

MetricBlue Haven RXClaya
WeighScore50.8/10062.8/100
GradeCC
Scorecard rank#489#264
SemaglutideNot disclosed$299/mo (compounded)
TirzepatideNot disclosed$299/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Blue Haven RX

Graded #489 · C

Strengths

  • Flat all-inclusive pricing — consult, prescription, medication and free shipping
  • Not charged until a US-licensed physician approves your prescription
  • Named operating entity disclosed (Eternum Health LLC)
  • Both compounded semaglutide and tirzepatide listed as in-stock

Where it loses points

  • Mixed third-party reviews — Trustpilot complaints on customer service and dosing
  • Doesn't publish the states it serves or specific pharmacy partners
  • No clearly verifiable accreditation badge (e.g. LegitScript) on the site
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
Claya

Graded #264 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard